Riskpilot← Back to searchSign inGet full accessMobidiag Oy
OYActiveY-tunnus 1651007-2Keilaranta 16-AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20008 employeeswww.mobidiag.com
Revenue 2025
EUR 1,8M
-96% vs 2024
EBITDA margin
-491.9%
-190% vs 2024
Equity ratio
78.3%
Financial strength
Net profit 2025
EUR -7,8M
-171% vs 2024
| Revenue | EUR 1,8M | -96% |
| EBITDA | EUR -8,9M | -190% |
| Net profit | EUR -7,8M | -171% |
| Total assets | EUR 38M | -31% |
| Equity | EUR 29,8M | -21% |
| Employees | 8 | — |
Legal name
Mobidiag Oy
Y-tunnus number
1651007-2
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25. heinäkuuta 2000
Share capital
EUR 10 424 010
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimiala on diagnostisten tuotteiden ja palvelujen tuottaminen ja myynti. Yhtiö voi harjoittaa toimialansa mukaista toimintaa myös tytär- ja osakkuusyhtiöiden avulla. Yhtiö voi ostaa, omistaa, hallita ja myydä osakeyhtiöiden ja osuuskuntien osakkeita ja osuuksia sekä harjoittaa arvopaperien kauppaa. Yhtiö voi omistaa, hallita, vuokrata ja myydä kiinteistöjä ja asunto- sekä kiinteistöosakeyhtiöiden osakkeita.
Address
Keilaranta 16-A
Phone
+3580105050770
Email
info@mobidiag.com
Website
www.mobidiag.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 31 358 | 27 931 | 10 414 | 41 084 | 1 813 |
| Staff expenses | −4 272 | −14 111 | −12 922 | −15 455 | −1 925 |
| EBITDA | 4 164 | −38 663 | −88 654 | 9 905 | −8 920 |
| Depreciation & amort. | −5 736 | −8 725 | −55 189 | −1 252 | −0 |
| EBIT | −1 573 | −47 388 | −143 842 | 8 653 | −8 920 |
| Net financials | −3 671 | −6 913 | −1 179 | 2 393 | 1 110 |
| Profit before tax | −5 244 | −54 300 | −145 021 | 11 046 | −7 809 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −5 244 | −54 300 | −145 021 | 11 046 | −7 809 |
| Item | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 67 963 | 74 192 | 44 434 | 54 894 | 38 037 |
| Equity | 13 099 | 8 925 | 6 705 | 37 603 | 29 794 |
| Long-term debt | 44 725 | 48 000 | 0 | 0 | 598 |
| Short-term debt | 10 139 | 16 585 | 37 330 | 8 039 | 7 575 |
| Total debt | 54 864 | 64 585 | 37 330 | 8 039 | 8 173 |
EBITDA margin
-491.9%
This company
15.8%
Market median
-3213% vs market
20202025
Equity ratio
78.3%
This company
38.2%
Market median
+105% vs market
20202025
Return on equity
-26.2%
This company
18.4%
Market median
-242% vs market
20202025
Net profit margin
-430.7%
This company
8.1%
Market median
-5417% vs market
20202025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202025
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202025
- Annual report 2025Filed via PRH / YTJ · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-10-01 – 2022-09-30
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
TJ Chief Executive Officer | Chief Executive Officer | 2013 – 2022 |
MR Person with significant control | Person with significant control | 2022 – 2024 |
MA | Audit | 2008 – 2021 |
HT | Audit | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairperson | 2021 | |
| Board of Directors | 2021 | |
| Former (9) | ||
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2021 – 2024 | |
| Chairperson | 2017 – 2021 | |
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2017 – 2019 | |
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2017 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hologic Nordic Holdings Oy
Mobidiag Oy (this company)Mobidiag Sverige AB, RuotsiGenewave S.A.S., RanskaMobidiag UK, Iso-BritanniaBoard members of Mobidiag Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tuomas Juhani Tenkanen | Chief Executive Officer | 0 companies |
| Minna Riikka Koivula | Person with significant control | 0 companies |
| Martin Andreas Grandell | Audit | 0 companies |
| Harri Tapio Kauttonen | Audit | 0 companies |
| Hannu Tapani Syrjälä | Board of Directors | 0 companies |
| Joseph John Kisby | Board of Directors | 0 companies |
| Jan Valeer M. Verstreken | Chairperson | 0 companies |
| John Joseph O'Shea | Board of Directors | 0 companies |
| Rabbe Ilari Klemets | Chairperson | 0 companies |
| Nils Göran Pettersson | Board of Directors | 0 companies |
| Juha Petteri Kirveskari | Board of Directors | 0 companies |
| Jean Francois Charles de Gunzburg | Board of Directors | 0 companies |
| Michelangelo Stefani | Board of Directors | 0 companies |
| Chaojie Feng | Board of Directors | 0 companies |
| Joseph Edward Bernardo | Board of Directors | 0 companies |
| Pekka Allan Antero Mattila | Board of Directors | 0 companies |